DE10081621D2 - Promotorsystem, dessen Herstellung und Verwendung - Google Patents

Promotorsystem, dessen Herstellung und Verwendung

Info

Publication number
DE10081621D2
DE10081621D2 DE10081621T DE10081621T DE10081621D2 DE 10081621 D2 DE10081621 D2 DE 10081621D2 DE 10081621 T DE10081621 T DE 10081621T DE 10081621 T DE10081621 T DE 10081621T DE 10081621 D2 DE10081621 D2 DE 10081621D2
Authority
DE
Germany
Prior art keywords
manufacture
promoter system
promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE10081621T
Other languages
English (en)
Inventor
Thomas Roitsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE10081621T priority Critical patent/DE10081621D2/de
Application granted granted Critical
Publication of DE10081621D2 publication Critical patent/DE10081621D2/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823—Reproductive tissue-specific promoters
    • C12N15/8231—Male-specific, e.g. anther, tapetum, pollen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
    • C12N15/8289—Male sterility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE10081621T 1999-06-12 2000-06-13 Promotorsystem, dessen Herstellung und Verwendung Ceased DE10081621D2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE10081621T DE10081621D2 (de) 1999-06-12 2000-06-13 Promotorsystem, dessen Herstellung und Verwendung

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE29909998 1999-06-12
DE20005992 2000-04-04
DE20007494 2000-04-26
PCT/DE2000/001944 WO2000077187A2 (de) 1999-06-12 2000-06-13 Promotorsystem, dessen herstellung und verwendung
DE10081621T DE10081621D2 (de) 1999-06-12 2000-06-13 Promotorsystem, dessen Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
DE10081621D2 true DE10081621D2 (de) 2002-05-29

Family

ID=27219434

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10081621T Ceased DE10081621D2 (de) 1999-06-12 2000-06-13 Promotorsystem, dessen Herstellung und Verwendung

Country Status (6)

Country Link
US (1) US7012173B1 (de)
EP (1) EP1183379A2 (de)
AU (1) AU6259800A (de)
CA (1) CA2376437A1 (de)
DE (1) DE10081621D2 (de)
WO (1) WO2000077187A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003294705A1 (en) * 2002-11-06 2004-06-07 Arc Seibersdorf Research Gmbh NtSM GENE
US20050120418A1 (en) * 2003-11-06 2005-06-02 Anawah Inc. Tomatoes having altered acid invertase activity due to non-transgenic alterations in acid invertase genes
CN101037695B (zh) * 2006-03-16 2011-08-17 华中农业大学 一种控制水稻花粉育性基因及应用
CN106480026B (zh) * 2016-09-29 2019-01-29 北京大学 一种花药早期发育特异性表达启动子及其应用
CN112760334B (zh) * 2021-01-18 2022-07-19 沈阳农业大学 调控番茄果实糖含量的基因及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9705694D0 (en) * 1997-03-19 1997-05-07 Scottish Crop Research Inst Polynucleotide
US6037523A (en) * 1997-06-23 2000-03-14 Pioneer Hi-Bred International Male tissue-preferred regulatory region and method of using same

Also Published As

Publication number Publication date
WO2000077187A3 (de) 2001-08-09
WO2000077187A2 (de) 2000-12-21
EP1183379A2 (de) 2002-03-06
US7012173B1 (en) 2006-03-14
CA2376437A1 (en) 2000-12-21
AU6259800A (en) 2001-01-02

Similar Documents

Publication Publication Date Title
DE69529026D1 (de) Trehalose, ihre Herstellung und ihre Verwendung
DE60038200D1 (de) ren Herstellung und Verwendung
EE200200175A (et) Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
ATE286021T1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
DE69916828D1 (de) Pyrazoline, ihre herstellung und verwendung als medikamente
DE10084441T1 (de) Koalinton-Pigmente, ihre Herstellung und Verwendung
ATE261449T1 (de) Thienopyrimidin verbindungen, ihre herstellung und verwendung
ZA200201494B (en) Benzodiazepin derivatives, the production and use thereof.
DE69901177D1 (de) Platinkomplex, dessen herstellung und dessen therapeutische verwendung
ATE302604T1 (de) Thienylazolylalkoxyethanamine, deren herstellung und deren verwendung als medikamente
ATE231869T1 (de) Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE60235547D1 (de) En daraus, deren herstellung und verwendung
DE60015004D1 (de) Russ, seine Herstellung und Verwendungen
ATE335000T1 (de) Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung
DE60103054D1 (de) Phenyloxazol-1,4-diazabicyclo[3.2.2]nonanderivate, ihre herstellung und ihre therapeutische verwendung
DE59710272D1 (de) Neue alpha-hydroxysäurederivate, ihre herstellung und verwendung
ATE261959T1 (de) Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung
ATE242197T1 (de) 3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung
DE60041418D1 (de) Zusammensetzung für hydrogele, hydrogel und dessen verwendung
ATE533768T1 (de) Imidazol-derivate, ihre herstellung und ihre verwendung
ATE251170T1 (de) Titanverbindungen, deren herstellung und verwendung
DE69810521D1 (de) Abbeizzusammensetzungen, ihre Herstellung und Verwendung
DE59802922D1 (de) 3-substituierte tetrahydropyridopyrimidinon-derivate, ihre herstellung und verwendung
DE1039889T1 (de) Immunoglobulinreiche milch, dessen herstellung und verwendung

Legal Events

Date Code Title Description
8131 Rejection